Simulations Plus (SLP) Expected to Announce Quarterly Earnings on Monday

Simulations Plus (NASDAQ:SLP) is projected to issue its Q3 2025 quarterly earnings data after the market closes on Monday, July 14th. Analysts expect the company to announce earnings of $0.29 per share and revenue of $22.83 million for the quarter.

Simulations Plus Price Performance

Simulations Plus stock opened at $16.96 on Friday. The firm’s fifty day moving average price is $24.77 and its 200 day moving average price is $28.37. The company has a market capitalization of $341.07 million, a price-to-earnings ratio of 48.46 and a beta of 0.83. Simulations Plus has a 12-month low of $16.72 and a 12-month high of $44.33.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the completion of the sale, the director owned 3,344,157 shares in the company, valued at approximately $112,062,701.07. This represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 19.40% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Royal Bank of Canada lifted its position in shares of Simulations Plus by 26.6% during the 1st quarter. Royal Bank of Canada now owns 114,885 shares of the technology company’s stock valued at $2,817,000 after buying an additional 24,132 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Simulations Plus during the 1st quarter valued at $255,000. Woodline Partners LP raised its stake in shares of Simulations Plus by 32.1% during the 1st quarter. Woodline Partners LP now owns 13,239 shares of the technology company’s stock valued at $325,000 after purchasing an additional 3,220 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Simulations Plus by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after purchasing an additional 390 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Wall Street Zen upgraded Simulations Plus from a “sell” rating to a “hold” rating in a research note on Monday, April 28th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a report on Tuesday, June 3rd. BTIG Research dropped their price objective on Simulations Plus from $41.00 to $25.00 and set a “buy” rating for the company in a research report on Monday, July 7th. JMP Securities reiterated a “market perform” rating on shares of Simulations Plus in a research report on Wednesday, June 18th. Finally, Craig Hallum dropped their target price on Simulations Plus from $45.00 to $36.00 and set a “buy” rating for the company in a research report on Friday, June 13th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $35.00.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.